Pradžia › Plaučių hipertenzija › Utah
Plaučių hipertenzija klinikiniai tyrimai Utah
7 tyrimai dėl Plaučių hipertenzija ieško dalyvių vietose Utah.
Miestai Utah
Oficialus tyrimo tekstas (anglų kalba)
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA025, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Utah, Salt Lake City
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06388421De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- University of Utah & Primary Children's Hospital (Utah-PCH), Salt Lake City
Renkami dalyviai4 fazė
0 Months – 1 Month · Visoms lytims · Atnaujinta 2026-08-18 · NCT05213676Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Utah Hospital, Salt Lake City
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT06526195Pulmonary Hypertension Association Registry
- University of Utah Health, Salt Lake City
Renkami dalyviaiStebimasis tyrimas
Amžius 0 ir vyresni · Visoms lytims · Atnaujinta 2025-11-14 · NCT04071327A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
- Primary Children's Hospital, Salt Lake City
Renkami dalyviai2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2025-04-04 · NCT05201144Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.